Skip to product information

2024 Hematology and Oncology Best Practices On demand – Full 8 Day Sessions

2024 Hematology and Oncology Best Practices On demand – Full 8 Day Sessions

Regular price $50.00 USD
Regular price $50.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
2024 Hematology and Oncology Best Practices On demand – Full 8 Day Sessions

2024 Hematology and Oncology Best Practices On demand – Full 8 Day Sessions

Regular price $50.00
Regular price $50.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details


    2024 HEMATOLOGY AND ONCOLOGY BEST PRACTICES - FULL SESSION The most comprehensive board review for physicians preparing to take the Hematology and Oncology certification exams or those desiring a comprehensive update of hematology and medical oncology standards of care.

    COURSE OVERVIEW
    PDF icon2024 HEMONC Best Practices Course Syllabus- Full Session.pdf
    COURSE CONTENT
    This online course is divided into 3 modules:


     
    Hematology Sessions:
    • Home Study/Enduring Sessions: Anemias, Porphyrias, Red Cell Enzymes, Clotting and Cellular Morphology (4.00 hours)
    • Live Session 1: Hemolytic Anemia, ITP Drug-Induced Thromboycytopenia, Consumptive Thrombohemorrhagic Disorders, Transfusion Medicine and Platelet Alloimmunization (9.00 hours)
    • Live Session 2: Hemoglobinopathies, White Cell Disorders, Bone Marrow Failure, Sickle Cell Disease, DIC, Anti-PF4 Disorders and Hematologic Complications of Pregnancy (8.75 hours)
    Hematologic Malignancies Sessions:
    • Live Session 3: Lymphomas, CLL, ALL, CML, Plasma Cell Disorders, and MGUS (9.25 hours)
    • Live Session 4: AML, Bone Marrow Transplantation, Myeloproliferative Neoplasms and Pharmacology (9.25 hours)
    Medical Oncology Sessions:
    • Live Session 5: Breast Cancer, Renal Cancer, Bladder, and Neuro-Oncology (9.00 hours)
    • Live Session 6: Lung Cancer, Prostate, Testicular, Mesothelioma, Ovarian and Endometrial Tumors (10.00 hours)
    • Live Session 7: GI Oncology and Sarcomas (6.75 hours)

     

    COURSE FEATURES

    All registered attendees receive:
    • A comprehensive review of Hematology and Oncology exam-focused content guided by the ABIM exam blueprint
    • Instruction by the nation's leading clinician-educators
    • Daily Board Review Sessions- Allows attendees to gauge their knowledge base and become familiar with Interactive case-based board-type questions
    • Access to Course Electronic Syllabus and Slide Handouts
    • Access to the archived course recordings until Wednesday, December 31, 2025
    • All content can be conveniently accessed from your computer, mobile device, or smartphone
    • CME credits and MOC points

    LEARNING OBJECTIVES



    At the conclusion of the Hematology and Oncology Best Practices course, the successful learner will be able to:

    Hematology
    • Understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors
    • Understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies
    • Understand blood and marrow morphology and hematopathology
    • Understand red cell disorders
    Hematologic Malignancies
    • Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs
    • Be familiar with the diagnosis, evaluation, and management of hematologic malignancies
    • Identify strategies for taking the board examinations
    Oncology
    • Understand the epidemiology of malignant diseases and management of the medical complications of malignancy
    • Comprehend the principles of management of gynecologic and other genito-urinary malignancies
    • Identify the latest advances in cancers of the lung, the breast, and the gastrointestinal tract
    • Recognize principles of new developments in biologic therapy of cancer